Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Orthofix Medical Inc.OFIX · Entity 1975 | President Spine Fixation | June 20, 2018 | June 21, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Orthofix Medical Inc.
Report date June 20, 2018 · Filed June 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,859 |
Ending reported balance
After 2018-06-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2018-06-20 · Exercise / conversion · Acquired 10,000 · Balance 36,352 F1: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Row 2 · 2018-06-20 · Exercise / conversion · Acquired 8,750 · Balance 45,102 F1: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Row 3 · 2018-06-20 · Sale · Disposed 28,047 · Balance 17,055 F2: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.40, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Row 4 · 2018-06-20 · Sale · Disposed 4,196 · Balance 12,859 F2: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $60.61, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.75 · Expires 2023-08-01 | Direct | 0 |
Reported balance
After 2018-06-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-06-20 · Exercise / conversion · Disposed 10,000 · Balance 0 F1: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $21.78 · Expires 2023-09-26 | Direct | 0 |
Reported balance
After 2018-06-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-06-20 · Exercise / conversion · Disposed 8,750 · Balance 0 F1: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
F2: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.40, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $60.61, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionStock Option (right to buy) · Derivative | 8,750 | $0.00 Strike: $21.78 | $0.00 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · derivative · entry 6 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires 2023-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $22.75 | $0.00 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · derivative · entry 5 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 4,196 | $60.49 | $253,832.82 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · nonDerivative · entry 4 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,859 F2 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $60.61, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 28,047 | $60.16 | $1,687,369.22 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · nonDerivative · entry 3 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,055 F2 · kind: The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.40, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 8,750 | $21.78 | $190,575.00 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · nonDerivative · entry 2 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| June 20, 2018 Filed Jun 21, 2018 20:42 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | Exercise / conversionCommon Stock | 10,000 | $22.75 | $227,500.00 |
DisclosureSEC source: 0001209191-18-038962 · doc4.xml · nonDerivative · entry 1 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:44 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 4,616 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023313 · doc4.xml · derivative · entry 3 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,616 Underlying: Common Stock · 4,616 shares Expires 2021-04-02 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as April 2, 2018 to April 2, 2021. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of April 2, 2018, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:44 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 8,193 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001209191-18-023313 · doc4.xml · derivative · entry 2 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,193 Underlying: Common Stock · 8,193 shares Expires 2028-04-02 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 22:44 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023313 · doc4.xml · nonDerivative · entry 1 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,352 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, April 2, 2018. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 21:03 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | SaleCommon Stock | 6,364 | $47.06 | $299,501.93 |
DisclosureSEC source: 0001209191-17-048784 · doc4.xml · nonDerivative · entry 1 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,084 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.00 to $47.25, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:04 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantPerformance Share Units · Derivative | 4,881 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044662 · doc4.xml · derivative · entry 3 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,881 Underlying: Common Stock · 4,881 shares Expires 2020-07-03 F3 · derivative.exercise_date: Represents market-based vesting performance stock units ("PSUs") that will settle as common stock on a one-for-one basis. The performance period of the grant is defined as July 3, 2017 to July 3, 2020. The PSUs will vest based on the percentile rank of the Company's total shareholder return ("TSR") over the performance period in relation to the TSR of the specified index companies. The index companies are based upon the companies included within the S&P Healthcare Select Sector index as of July 3, 2017, the grant date. In the event that the Company's TSR ranks at the 75th percentile or greater for the performance period, 200% of the PSUs will vest. In the event that the Company's TSR ranks between the 50th percentile and the 75th percentile, 100-200% of the PSUs will vest and 50-100% of the PSUs will vest if the Company's TSR ranks between the 25th percentile and 50th percentile. No PSUs will vest if the Company ranks below the 25th percentile. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:04 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantStock Option (right to buy) · Derivative | 8,516 | $0.00 Strike: $46.10 | $0.00 |
DisclosureSEC source: 0001209191-17-044662 · doc4.xml · derivative · entry 2 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,516 Underlying: Common Stock · 8,516 shares Expires 2027-07-03 F2 · derivative.exercise_date: These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
| July 03, 2017 Filed Jul 10, 2017 22:04 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044662 · doc4.xml · nonDerivative · entry 1 FUJIKAWA RAYMOND · CIK 0001669831 · President Spine Fixation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,448 F1 · shares: Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 3, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.